
Sign up to save your podcasts
Or


We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.
By Retina Synthesis4.5
88 ratings
We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.

43 Listeners

18 Listeners

97 Listeners

112,484 Listeners

56,740 Listeners

5 Listeners

9,554 Listeners

11 Listeners

47,730 Listeners

50 Listeners

11 Listeners

464 Listeners

19 Listeners

0 Listeners